SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000792977-20-000092
Filing Date
2020-10-06
Accepted
2020-10-05 21:56:18
Documents
17
Period of Report
2020-10-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amag-20201005.htm   iXBRL 8-K 48132
2 EX-99.1 amag10520ex991.htm EX-99.1 17799
8 amag-20201005_g1.jpg GRAPHIC 151973
9 image01.jpg GRAPHIC 151973
  Complete submission text file 0000792977-20-000092.txt   768536

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amag-20201005.xsd EX-101.SCH 2442
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amag-20201005_cal.xml EX-101.CAL 726
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amag-20201005_def.xml EX-101.DEF 1663
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amag-20201005_lab.xml EX-101.LAB 24270
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amag-20201005_pre.xml EX-101.PRE 12662
10 EXTRACTED XBRL INSTANCE DOCUMENT amag-20201005_htm.xml XML 10717
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 201225479
SIC: 2834 Pharmaceutical Preparations